| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/17/2011 | US7943595 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 05/17/2011 | US7943575 Sustained release drug formulations containing a carrier peptide |
| 05/17/2011 | US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943376 Platelet derived growth factor (PDGF)-derived neurospheres define a novel class of progenitor cells |
| 05/17/2011 | US7943338 Autoimmune conditions and NADPH oxidase defects |
| 05/17/2011 | US7943332 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 05/17/2011 | US7943174 Controlled release hydrocodone formulations |
| 05/17/2011 | US7943173 Pharmaceutical combinations of oxycodone and naloxone |
| 05/17/2011 | CA2688934C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/17/2011 | CA2560844C Pharmaceutical agent containing hyaluronan as an active ingredient |
| 05/17/2011 | CA2514267C Malonamide derivatives as gamma-secretase inhibitors |
| 05/17/2011 | CA2494574C 7-phenylpyrazolopyridine compounds |
| 05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
| 05/17/2011 | CA2463552C Treatment of neurodegenerative diseases and cancer of the brain |
| 05/17/2011 | CA2451521C Use of poly-glu, tyr for neuroprotective therapy |
| 05/17/2011 | CA2440726C Substituted benzofuran-2-carboxamides derivatives |
| 05/17/2011 | CA2437851C 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 05/17/2011 | CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/17/2011 | CA2414484C Muscle-strengthening drugs and anti-inflammatory drugs |
| 05/17/2011 | CA2413945C Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2401385C Protein matrix materials, devices and methods of making and using thereof |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/17/2011 | CA2376339C Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 05/17/2011 | CA2333582C Nicotine immunogen |
| 05/17/2011 | CA2114267C Use of oxidase inhibitor with dextromethorphan to treat intractable coughing and dermatitis |
| 05/12/2011 | WO2011057204A2 Lrrk2-mediated neuronal toxicity |
| 05/12/2011 | WO2011056972A2 Compositions and methods of treating a t cell mediated disorder |
| 05/12/2011 | WO2011056930A2 Fragile x mental retardation protein (fmrp), compositions, and methods related thereto |
| 05/12/2011 | WO2011056849A1 Methods of treating elevations in mtor signaling |
| 05/12/2011 | WO2011056788A2 Inhibiting neurotransmitter reuptake |
| 05/12/2011 | WO2011056773A2 Inhibiting neurotransmitter reuptake |
| 05/12/2011 | WO2011056604A2 Treatment of sunburn using analgesics and antihistamines |
| 05/12/2011 | WO2011056573A1 Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| 05/12/2011 | WO2011056503A1 Azabicyclo[2.2.1] heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| 05/12/2011 | WO2011056440A1 Heterocyclic compounds as ccr1 receptor antagonists |
| 05/12/2011 | WO2011056222A1 Methods of treating disorders associated with protein aggregation |
| 05/12/2011 | WO2011056174A1 Migraine headache relief composition |
| 05/12/2011 | WO2011056037A2 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts |
| 05/12/2011 | WO2011056033A2 Pharmaceutical composition for preventing / treating trpv1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient |
| 05/12/2011 | WO2011055965A2 Methods for treating attention-deficit/hyperactivity disorder |
| 05/12/2011 | WO2011055944A2 Methods for treating fibromyalgia syndrome |
| 05/12/2011 | WO2011055810A1 Dihydro pyrroloquinoline derivatives |
| 05/12/2011 | WO2011055561A1 Protein crosslinking inhibitor and use thereof |
| 05/12/2011 | WO2011055550A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 05/12/2011 | WO2011055247A1 A synthetic cyclic dipeptide and a process thereof |
| 05/12/2011 | WO2011054947A1 Thiadiazolidinedioxide p2x7 receptor antagonists |
| 05/12/2011 | WO2011054888A1 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
| 05/12/2011 | WO2011054885A1 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders |
| 05/12/2011 | WO2011054820A1 Methods and compositions for the treatment of white matter ischemia |
| 05/12/2011 | WO2011054773A1 Novel lactam compounds |
| 05/12/2011 | WO2011054759A1 New therapeutic approaches for treating alzheimer disease |
| 05/12/2011 | WO2011054301A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 05/12/2011 | WO2011054185A1 Optical isomers of aralkyl piperazine derivative, preparation methods and uses thereof |
| 05/12/2011 | WO2011054171A1 Tyrosine derivative histone deacetylases inhibitors and applications thereof |
| 05/12/2011 | WO2011005969A3 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 05/12/2011 | WO2010147677A3 Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone |
| 05/12/2011 | WO2010138387A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 05/12/2011 | WO2009140621A8 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112200 Solid states of o-desmethylvenlafaxine salts |
| 05/12/2011 | US20110112199 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 05/12/2011 | US20110112197 Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide |
| 05/12/2011 | US20110112196 Nrf2 screening assays and related methods and compositions |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112191 Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using same |
| 05/12/2011 | US20110112190 Orally active curcuminoid compounds |
| 05/12/2011 | US20110112189 Methods of treating pains associated with neuroma, nerve entrapment, and other conditions |
| 05/12/2011 | US20110112187 Use Of Tranilast And Derivatives Thereof For The Therapy Of Neurological Conditions |
| 05/12/2011 | US20110112186 Diagnostic methods |
| 05/12/2011 | US20110112182 Design, synthesis and functional characterization of rottlerin analogs |
| 05/12/2011 | US20110112177 Human G-Protein Coupled Receptor (HETGQ23) |
| 05/12/2011 | US20110112175 Peptide biosynthesis and pain therapy |
| 05/12/2011 | US20110112174 Peptide biosynthesis and pain therapy |
| 05/12/2011 | US20110112168 Novel sirna structures |
| 05/12/2011 | US20110112162 Spiro-oxindole compounds and their use as therapeutic agents |
| 05/12/2011 | US20110112159 Serotonin transporter gene and treament of alcoholism |
| 05/12/2011 | US20110112157 Process for the preparation of zolmitriptan, salts and solvates thereof |
| 05/12/2011 | US20110112156 Bicyclic Derivatives as Modulators of Voltage Gated ION Channels |
| 05/12/2011 | US20110112149 Epothilone analogues, their pharmaceutical compositions, their use and their prepa rations |
| 05/12/2011 | US20110112148 Indoline compounds |
| 05/12/2011 | US20110112145 Salts Of Methyl 2-((R))-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3((R)-tetrahydro-2H-Pyran-3-YL)Propylcarbamoyl)Piperidin-3-YL)Methoxy)Ethylcarbamate |
| 05/12/2011 | US20110112143 Allosteric modulators of metabotropic glutamate receptors |
| 05/12/2011 | US20110112142 Novel estrogen receptor ligands |
| 05/12/2011 | US20110112140 Inhibitor of plasminogen activator inhibitor-1 |
| 05/12/2011 | US20110112139 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/12/2011 | US20110112138 Multi-cyclic cinnamide derivatives |
| 05/12/2011 | US20110112133 Dihydro pyrroloquinoline derivatives |
| 05/12/2011 | US20110112131 Opioid-Ketamine and Norketamine Codrug Combinations for Pain Management |
| 05/12/2011 | US20110112130 Opioid-Nornicotine Codrugs Combinations for Pain Management |
| 05/12/2011 | US20110112122 EPIMINOCYCLOALKYL[b] INDOLE DERIVATIVES AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS AND USES THEREOF |
| 05/12/2011 | US20110112120 Heteromonocyclic compound and use thereof |
| 05/12/2011 | US20110112119 Azabicyclooctyl-quinazolone derivatives useful as nicotinic acetylcholine receptor modulators |
| 05/12/2011 | US20110112117 Treatment of herpes virus related diseases |
| 05/12/2011 | US20110112116 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions |
| 05/12/2011 | US20110112112 Apogossypolone derivatives as anticancer agents |
| 05/12/2011 | US20110112111 Drug combinations comprising a dgat inhibitor and a ppar-agonist |
| 05/12/2011 | US20110112107 Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists |
| 05/12/2011 | US20110112105 Substituted heterocycle fused gamma-carbolines solid |